An unusual about-face that played out at the FDA over the last week illustrated the power of the “Make America Healthy Again” ...

Europe, Ukraine hope for chilly Putin summit ▪ The Hill interview: Newsom defends redistricting fight ▪ Progressives take center stage in mayoral contests ▪ Israel steps up ...

Therapies for rare and deadly disease are dying in Marty Makary’s shop.

FDA warning letters highlight recurring patterns, systemic gaps, and evolving priorities that medical device manufacturers ...

Generative AI technology has tremendous potential for the healthcare industry, but we shouldn’t expect too much – especially if we’re the FDA.

Eastman Kodak Co. reported a second-quarter loss and a year-over-year drop in sales, as the company leans on a Rochester ...

This article was featured in One Great Story, New York ’s reading recommendation newsletter. Sign up here to get it nightly.

Some oncologists and researchers have raised concerns about delays in the completion of confirmatory trials, but FDA now has new tools to push them ahead.

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...

This data was produced from a multi-center study that enrolled 125 patients. The data demonstrates that VIVO was over 94% accurate, assisted physicians in determining workflow when used pre-procedure, ...

The U.S. Food and Drug Administration said on Friday it has approved Boehringer Ingelheim's drug for patients with a type of ...